img

Global HPV Therapeutic Vaccines Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global HPV Therapeutic Vaccines Market Insights, Forecast to 2034

Human papilloma virus (HPV) vaccines are used to protect against HPV infections.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
Market Analysis and InsightsGlobal HPV Therapeutic Vaccines Market
Global HPV Therapeutic Vaccines market is expected to reach to US$ 5155 million in 2024, with a positive growth of %, compared with US$ 4401 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, HPV Therapeutic Vaccines industry is evaluated to reach US$ 12480 million in 2029. The CAGR will be 15.9% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global HPV Therapeutic Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global HPV Therapeutic Vaccines market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck & Co., Inc
GlaxoSmithKline plc
Shanghai Bovax Biotechnology Co., Ltd.
Profectus BioSciences, Inc.
2A Pharma AB
ISA Pharmaceuticals
Pfizer
Sanofi Pasteur
Serum Institute
Emergent BioSolutions
Astellas Pharma
Johnson and Johnson.
Wantai BioPharm
INOVIO Pharmaceuticals
Segment by Type
Bivalent HPV vaccine
Quadrivalent HPV vaccine

Segment by Application


Man
Woman
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, HPV Therapeutic Vaccines introduction, etc. HPV Therapeutic Vaccines Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of HPV Therapeutic Vaccines
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HPV Therapeutic Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Bivalent HPV vaccine
1.2.3 Quadrivalent HPV vaccine
1.3 Market by Application
1.3.1 Global HPV Therapeutic Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Man
1.3.3 Woman
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global HPV Therapeutic Vaccines Market Perspective (2018-2029)
2.2 Global HPV Therapeutic Vaccines Growth Trends by Region
2.2.1 HPV Therapeutic Vaccines Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 HPV Therapeutic Vaccines Historic Market Size by Region (2018-2024)
2.2.3 HPV Therapeutic Vaccines Forecasted Market Size by Region (2024-2029)
2.3 HPV Therapeutic Vaccines Market Dynamics
2.3.1 HPV Therapeutic Vaccines Industry Trends
2.3.2 HPV Therapeutic Vaccines Market Drivers
2.3.3 HPV Therapeutic Vaccines Market Challenges
2.3.4 HPV Therapeutic Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue HPV Therapeutic Vaccines by Players
3.1.1 Global HPV Therapeutic Vaccines Revenue by Players (2018-2024)
3.1.2 Global HPV Therapeutic Vaccines Revenue Market Share by Players (2018-2024)
3.2 Global HPV Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of HPV Therapeutic Vaccines, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global HPV Therapeutic Vaccines Market Concentration Ratio
3.4.1 Global HPV Therapeutic Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HPV Therapeutic Vaccines Revenue in 2022
3.5 Global Key Players of HPV Therapeutic Vaccines Head office and Area Served
3.6 Global Key Players of HPV Therapeutic Vaccines, Product and Application
3.7 Global Key Players of HPV Therapeutic Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 HPV Therapeutic Vaccines Breakdown Data by Type
4.1 Global HPV Therapeutic Vaccines Historic Market Size by Type (2018-2024)
4.2 Global HPV Therapeutic Vaccines Forecasted Market Size by Type (2024-2029)
5 HPV Therapeutic Vaccines Breakdown Data by Application
5.1 Global HPV Therapeutic Vaccines Historic Market Size by Application (2018-2024)
5.2 Global HPV Therapeutic Vaccines Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America HPV Therapeutic Vaccines Market Size (2018-2029)
6.2 North America HPV Therapeutic Vaccines Market Size by Type
6.2.1 North America HPV Therapeutic Vaccines Market Size by Type (2018-2024)
6.2.2 North America HPV Therapeutic Vaccines Market Size by Type (2024-2029)
6.2.3 North America HPV Therapeutic Vaccines Market Share by Type (2018-2029)
6.3 North America HPV Therapeutic Vaccines Market Size by Application
6.3.1 North America HPV Therapeutic Vaccines Market Size by Application (2018-2024)
6.3.2 North America HPV Therapeutic Vaccines Market Size by Application (2024-2029)
6.3.3 North America HPV Therapeutic Vaccines Market Share by Application (2018-2029)
6.4 North America HPV Therapeutic Vaccines Market Size by Country
6.4.1 North America HPV Therapeutic Vaccines Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America HPV Therapeutic Vaccines Market Size by Country (2018-2024)
6.4.3 North America HPV Therapeutic Vaccines Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe HPV Therapeutic Vaccines Market Size (2018-2029)
7.2 Europe HPV Therapeutic Vaccines Market Size by Type
7.2.1 Europe HPV Therapeutic Vaccines Market Size by Type (2018-2024)
7.2.2 Europe HPV Therapeutic Vaccines Market Size by Type (2024-2029)
7.2.3 Europe HPV Therapeutic Vaccines Market Share by Type (2018-2029)
7.3 Europe HPV Therapeutic Vaccines Market Size by Application
7.3.1 Europe HPV Therapeutic Vaccines Market Size by Application (2018-2024)
7.3.2 Europe HPV Therapeutic Vaccines Market Size by Application (2024-2029)
7.3.3 Europe HPV Therapeutic Vaccines Market Share by Application (2018-2029)
7.4 Europe HPV Therapeutic Vaccines Market Size by Country
7.4.1 Europe HPV Therapeutic Vaccines Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe HPV Therapeutic Vaccines Market Size by Country (2018-2024)
7.4.3 Europe HPV Therapeutic Vaccines Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China HPV Therapeutic Vaccines Market Size (2018-2029)
8.2 China HPV Therapeutic Vaccines Market Size by Type
8.2.1 China HPV Therapeutic Vaccines Market Size by Type (2018-2024)
8.2.2 China HPV Therapeutic Vaccines Market Size by Type (2024-2029)
8.2.3 China HPV Therapeutic Vaccines Market Share by Type (2018-2029)
8.3 China HPV Therapeutic Vaccines Market Size by Application
8.3.1 China HPV Therapeutic Vaccines Market Size by Application (2018-2024)
8.3.2 China HPV Therapeutic Vaccines Market Size by Application (2024-2029)
8.3.3 China HPV Therapeutic Vaccines Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia HPV Therapeutic Vaccines Market Size (2018-2029)
9.2 Asia HPV Therapeutic Vaccines Market Size by Type
9.2.1 Asia HPV Therapeutic Vaccines Market Size by Type (2018-2024)
9.2.2 Asia HPV Therapeutic Vaccines Market Size by Type (2024-2029)
9.2.3 Asia HPV Therapeutic Vaccines Market Share by Type (2018-2029)
9.3 Asia HPV Therapeutic Vaccines Market Size by Application
9.3.1 Asia HPV Therapeutic Vaccines Market Size by Application (2018-2024)
9.3.2 Asia HPV Therapeutic Vaccines Market Size by Application (2024-2029)
9.3.3 Asia HPV Therapeutic Vaccines Market Share by Application (2018-2029)
9.4 Asia HPV Therapeutic Vaccines Market Size by Region
9.4.1 Asia HPV Therapeutic Vaccines Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia HPV Therapeutic Vaccines Market Size by Region (2018-2024)
9.4.3 Asia HPV Therapeutic Vaccines Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Type
10.2.1 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Application
10.3.1 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Country
10.4.1 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck & Co., Inc
11.1.1 Merck & Co., Inc Company Details
11.1.2 Merck & Co., Inc Business Overview
11.1.3 Merck & Co., Inc HPV Therapeutic Vaccines Introduction
11.1.4 Merck & Co., Inc Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.1.5 Merck & Co., Inc Recent Developments
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Details
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc HPV Therapeutic Vaccines Introduction
11.2.4 GlaxoSmithKline plc Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.2.5 GlaxoSmithKline plc Recent Developments
11.3 Shanghai Bovax Biotechnology Co., Ltd.
11.3.1 Shanghai Bovax Biotechnology Co., Ltd. Company Details
11.3.2 Shanghai Bovax Biotechnology Co., Ltd. Business Overview
11.3.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Introduction
11.3.4 Shanghai Bovax Biotechnology Co., Ltd. Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.3.5 Shanghai Bovax Biotechnology Co., Ltd. Recent Developments
11.4 Profectus BioSciences, Inc.
11.4.1 Profectus BioSciences, Inc. Company Details
11.4.2 Profectus BioSciences, Inc. Business Overview
11.4.3 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Introduction
11.4.4 Profectus BioSciences, Inc. Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.4.5 Profectus BioSciences, Inc. Recent Developments
11.5 2A Pharma AB
11.5.1 2A Pharma AB Company Details
11.5.2 2A Pharma AB Business Overview
11.5.3 2A Pharma AB HPV Therapeutic Vaccines Introduction
11.5.4 2A Pharma AB Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.5.5 2A Pharma AB Recent Developments
11.6 ISA Pharmaceuticals
11.6.1 ISA Pharmaceuticals Company Details
11.6.2 ISA Pharmaceuticals Business Overview
11.6.3 ISA Pharmaceuticals HPV Therapeutic Vaccines Introduction
11.6.4 ISA Pharmaceuticals Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.6.5 ISA Pharmaceuticals Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer HPV Therapeutic Vaccines Introduction
11.7.4 Pfizer Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.7.5 Pfizer Recent Developments
11.8 Sanofi Pasteur
11.8.1 Sanofi Pasteur Company Details
11.8.2 Sanofi Pasteur Business Overview
11.8.3 Sanofi Pasteur HPV Therapeutic Vaccines Introduction
11.8.4 Sanofi Pasteur Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.8.5 Sanofi Pasteur Recent Developments
11.9 Serum Institute
11.9.1 Serum Institute Company Details
11.9.2 Serum Institute Business Overview
11.9.3 Serum Institute HPV Therapeutic Vaccines Introduction
11.9.4 Serum Institute Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.9.5 Serum Institute Recent Developments
11.10 Emergent BioSolutions
11.10.1 Emergent BioSolutions Company Details
11.10.2 Emergent BioSolutions Business Overview
11.10.3 Emergent BioSolutions HPV Therapeutic Vaccines Introduction
11.10.4 Emergent BioSolutions Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.10.5 Emergent BioSolutions Recent Developments
11.11 Astellas Pharma
11.11.1 Astellas Pharma Company Details
11.11.2 Astellas Pharma Business Overview
11.11.3 Astellas Pharma HPV Therapeutic Vaccines Introduction
11.11.4 Astellas Pharma Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.11.5 Astellas Pharma Recent Developments
11.12 Johnson and Johnson.
11.12.1 Johnson and Johnson. Company Details
11.12.2 Johnson and Johnson. Business Overview
11.12.3 Johnson and Johnson. HPV Therapeutic Vaccines Introduction
11.12.4 Johnson and Johnson. Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.12.5 Johnson and Johnson. Recent Developments
11.13 Wantai BioPharm
11.13.1 Wantai BioPharm Company Details
11.13.2 Wantai BioPharm Business Overview
11.13.3 Wantai BioPharm HPV Therapeutic Vaccines Introduction
11.13.4 Wantai BioPharm Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.13.5 Wantai BioPharm Recent Developments
11.14 INOVIO Pharmaceuticals
11.14.1 INOVIO Pharmaceuticals Company Details
11.14.2 INOVIO Pharmaceuticals Business Overview
11.14.3 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Introduction
11.14.4 INOVIO Pharmaceuticals Revenue in HPV Therapeutic Vaccines Business (2018-2024)
11.14.5 INOVIO Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global HPV Therapeutic Vaccines Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Bivalent HPV vaccine
Table 3. Key Players of Quadrivalent HPV vaccine
Table 4. Global HPV Therapeutic Vaccines Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global HPV Therapeutic Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global HPV Therapeutic Vaccines Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global HPV Therapeutic Vaccines Market Share by Region (2018-2024)
Table 8. Global HPV Therapeutic Vaccines Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global HPV Therapeutic Vaccines Market Share by Region (2024-2029)
Table 10. HPV Therapeutic Vaccines Market Trends
Table 11. HPV Therapeutic Vaccines Market Drivers
Table 12. HPV Therapeutic Vaccines Market Challenges
Table 13. HPV Therapeutic Vaccines Market Restraints
Table 14. Global HPV Therapeutic Vaccines Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global HPV Therapeutic Vaccines Revenue Share by Players (2018-2024)
Table 16. Global Top HPV Therapeutic Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HPV Therapeutic Vaccines as of 2022)
Table 17. Global HPV Therapeutic Vaccines Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by HPV Therapeutic Vaccines Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of HPV Therapeutic Vaccines, Headquarters and Area Served
Table 20. Global Key Players of HPV Therapeutic Vaccines, Product and Application
Table 21. Global Key Players of HPV Therapeutic Vaccines, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global HPV Therapeutic Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global HPV Therapeutic Vaccines Revenue Market Share by Type (2018-2024)
Table 25. Global HPV Therapeutic Vaccines Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global HPV Therapeutic Vaccines Revenue Market Share by Type (2024-2029)
Table 27. Global HPV Therapeutic Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global HPV Therapeutic Vaccines Revenue Share by Application (2018-2024)
Table 29. Global HPV Therapeutic Vaccines Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global HPV Therapeutic Vaccines Revenue Share by Application (2024-2029)
Table 31. North America HPV Therapeutic Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America HPV Therapeutic Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America HPV Therapeutic Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America HPV Therapeutic Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America HPV Therapeutic Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America HPV Therapeutic Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America HPV Therapeutic Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe HPV Therapeutic Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe HPV Therapeutic Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe HPV Therapeutic Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe HPV Therapeutic Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe HPV Therapeutic Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe HPV Therapeutic Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe HPV Therapeutic Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 45. China HPV Therapeutic Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 46. China HPV Therapeutic Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 47. China HPV Therapeutic Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 48. China HPV Therapeutic Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia HPV Therapeutic Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia HPV Therapeutic Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia HPV Therapeutic Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia HPV Therapeutic Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia HPV Therapeutic Vaccines Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia HPV Therapeutic Vaccines Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia HPV Therapeutic Vaccines Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size by Country (2024-2029) & (US$ Million)
Table 63. Merck & Co., Inc Company Details
Table 64. Merck & Co., Inc Business Overview
Table 65. Merck & Co., Inc HPV Therapeutic Vaccines Product
Table 66. Merck & Co., Inc Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 67. Merck & Co., Inc Recent Developments
Table 68. GlaxoSmithKline plc Company Details
Table 69. GlaxoSmithKline plc Business Overview
Table 70. GlaxoSmithKline plc HPV Therapeutic Vaccines Product
Table 71. GlaxoSmithKline plc Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 72. GlaxoSmithKline plc Recent Developments
Table 73. Shanghai Bovax Biotechnology Co., Ltd. Company Details
Table 74. Shanghai Bovax Biotechnology Co., Ltd. Business Overview
Table 75. Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Product
Table 76. Shanghai Bovax Biotechnology Co., Ltd. Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 77. Shanghai Bovax Biotechnology Co., Ltd. Recent Developments
Table 78. Profectus BioSciences, Inc. Company Details
Table 79. Profectus BioSciences, Inc. Business Overview
Table 80. Profectus BioSciences, Inc. HPV Therapeutic Vaccines Product
Table 81. Profectus BioSciences, Inc. Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 82. Profectus BioSciences, Inc. Recent Developments
Table 83. 2A Pharma AB Company Details
Table 84. 2A Pharma AB Business Overview
Table 85. 2A Pharma AB HPV Therapeutic Vaccines Product
Table 86. 2A Pharma AB Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 87. 2A Pharma AB Recent Developments
Table 88. ISA Pharmaceuticals Company Details
Table 89. ISA Pharmaceuticals Business Overview
Table 90. ISA Pharmaceuticals HPV Therapeutic Vaccines Product
Table 91. ISA Pharmaceuticals Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 92. ISA Pharmaceuticals Recent Developments
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer HPV Therapeutic Vaccines Product
Table 96. Pfizer Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 97. Pfizer Recent Developments
Table 98. Sanofi Pasteur Company Details
Table 99. Sanofi Pasteur Business Overview
Table 100. Sanofi Pasteur HPV Therapeutic Vaccines Product
Table 101. Sanofi Pasteur Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 102. Sanofi Pasteur Recent Developments
Table 103. Serum Institute Company Details
Table 104. Serum Institute Business Overview
Table 105. Serum Institute HPV Therapeutic Vaccines Product
Table 106. Serum Institute Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 107. Serum Institute Recent Developments
Table 108. Emergent BioSolutions Company Details
Table 109. Emergent BioSolutions Business Overview
Table 110. Emergent BioSolutions HPV Therapeutic Vaccines Product
Table 111. Emergent BioSolutions Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 112. Emergent BioSolutions Recent Developments
Table 113. Astellas Pharma Company Details
Table 114. Astellas Pharma Business Overview
Table 115. Astellas Pharma HPV Therapeutic Vaccines Product
Table 116. Astellas Pharma Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 117. Astellas Pharma Recent Developments
Table 118. Johnson and Johnson. Company Details
Table 119. Johnson and Johnson. Business Overview
Table 120. Johnson and Johnson. HPV Therapeutic Vaccines Product
Table 121. Johnson and Johnson. Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 122. Johnson and Johnson. Recent Developments
Table 123. Wantai BioPharm Company Details
Table 124. Wantai BioPharm Business Overview
Table 125. Wantai BioPharm HPV Therapeutic Vaccines Product
Table 126. Wantai BioPharm Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 127. Wantai BioPharm Recent Developments
Table 128. INOVIO Pharmaceuticals Company Details
Table 129. INOVIO Pharmaceuticals Business Overview
Table 130. INOVIO Pharmaceuticals HPV Therapeutic Vaccines Product
Table 131. INOVIO Pharmaceuticals Revenue in HPV Therapeutic Vaccines Business (2018-2024) & (US$ Million)
Table 132. INOVIO Pharmaceuticals Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HPV Therapeutic Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global HPV Therapeutic Vaccines Market Share by Type: 2022 VS 2029
Figure 3. Bivalent HPV vaccine Features
Figure 4. Quadrivalent HPV vaccine Features
Figure 5. Global HPV Therapeutic Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global HPV Therapeutic Vaccines Market Share by Application: 2022 VS 2029
Figure 7. Man Case Studies
Figure 8. Woman Case Studies
Figure 9. HPV Therapeutic Vaccines Report Years Considered
Figure 10. Global HPV Therapeutic Vaccines Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global HPV Therapeutic Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global HPV Therapeutic Vaccines Market Share by Region: 2022 VS 2029
Figure 13. Global HPV Therapeutic Vaccines Market Share by Players in 2022
Figure 14. Global Top HPV Therapeutic Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HPV Therapeutic Vaccines as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by HPV Therapeutic Vaccines Revenue in 2022
Figure 16. North America HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America HPV Therapeutic Vaccines Market Share by Type (2018-2029)
Figure 18. North America HPV Therapeutic Vaccines Market Share by Application (2018-2029)
Figure 19. North America HPV Therapeutic Vaccines Market Share by Country (2018-2029)
Figure 20. United States HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe HPV Therapeutic Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe HPV Therapeutic Vaccines Market Share by Type (2018-2029)
Figure 24. Europe HPV Therapeutic Vaccines Market Share by Application (2018-2029)
Figure 25. Europe HPV Therapeutic Vaccines Market Share by Country (2018-2029)
Figure 26. Germany HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China HPV Therapeutic Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China HPV Therapeutic Vaccines Market Share by Type (2018-2029)
Figure 34. China HPV Therapeutic Vaccines Market Share by Application (2018-2029)
Figure 35. Asia HPV Therapeutic Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia HPV Therapeutic Vaccines Market Share by Type (2018-2029)
Figure 37. Asia HPV Therapeutic Vaccines Market Share by Application (2018-2029)
Figure 38. Asia HPV Therapeutic Vaccines Market Share by Region (2018-2029)
Figure 39. Japan HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America HPV Therapeutic Vaccines Market Share by Country (2018-2029)
Figure 49. Brazil HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries HPV Therapeutic Vaccines Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Merck & Co., Inc Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 56. GlaxoSmithKline plc Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 57. Shanghai Bovax Biotechnology Co., Ltd. Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 58. Profectus BioSciences, Inc. Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 59. 2A Pharma AB Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 60. ISA Pharmaceuticals Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 61. Pfizer Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 62. Sanofi Pasteur Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 63. Serum Institute Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 64. Emergent BioSolutions Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 65. Astellas Pharma Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 66. Johnson and Johnson. Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 67. Wantai BioPharm Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 68. INOVIO Pharmaceuticals Revenue Growth Rate in HPV Therapeutic Vaccines Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries